Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia

Chemerin is dysregulation in numerous solid cancers. However, only little is known about the role of chemerin in acute myeloid leukemia (AML). In this study, we aimed to investigate the expression and clinical significance of recently described chemerin in acute myeloid leukemia (AML). The expressio...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Zhang, Jing, Zhou, Jiao, Tang, Xi, Zhou, Ling-Yu, Zhai, Ling-Ling, Vanessa, Minse Evola-Deniz, Yi, Jing, Yi, Yun-Yun, Lin, Jiang, Qian, Jun, Deng, Zhao-Qun
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5696201/
https://ncbi.nlm.nih.gov/pubmed/29190935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21440
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki